Brainstorm Cell Therapeutics: MSC-NTF Cell Therapy Shows Mid-Stage Promise In PMS
I rate Brainstorm Cell Therapeutics stock as a “hold” with a positive outlook. Here is my analysis on this…
FuboTV’s Growth Points To A Potential 100%+ Valuation Expansion
FuboTV (FUBO) is snowballing in the underserved market of sports streaming, with the potential to enable great sports betting…
Zoom: Moved To Strong Buy Rating
Zoom could actually be a post-Covid darling opposite of what everybody thinks. The company reports earnings on 1 June….
LendingClub: The Very Real Path To 10x Returns For Shareholders
The market is completely underestimating the earnings that LendingClub can generate from holding prime personal loans. Here is why…
EPS: Cheaper Than SPY, And More Meritocratic
The EPS exchange-traded fund presents an alternative to the market-cap weighted SPY. Click here to see which is a…
Pfizer: mRNA COVID Vaccine Is Transforming And More To Come
Pfizer brought its mRNA COVID vaccine to the market, but with no impact on its stock price. This makes…
CNX Resources: Giving Them A Pass At Current Prices
CNX Resources stock has underperformed the market in relation to peers the last few months. We discuss some possible…
7.6% Yield, 32% Insider Ownership, Set To Soar: Enterprise Products Partners
EPD faces strong tailwinds with tight demand for commodities and a super-charged economy. It boasts 22 years of consistent…
Iovance: Down And Rebound
Despite recent uncertainty, Iovance made a huge comeback announcing superb data for its lead franchise, lifileucel. Read more on…
Cimarex Energy and Cabot Oil & Gas deal not seeing much love from Wall Street
Cimarex Energy (XEC) all-stock merger with Cabot Oil & Gas (COG) didn’t get the reception the companies likely expected…
recent post
-
May 17 2025 -
May 17 2025
-
May 17 2025
-
-
May 17 2025
